Cancer

Multiple myeloma, a cancer of plasma cells, has seen significant advancements in treatment options over recent years. One of the most promising developments has been the use of antibody therapies, particularly CD38 antibodies and bispecific antibodies. As healthcare providers integrate these therapies into their practice, it is essential to stay informed about the latest…